Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence?
UC expert says research may be useful, but more trials are needed
A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 treatment arsenal. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Creative + Brand
"This research might be valuable, but the jury remains out until several other adequately powered and designed trials are completed," said Fichtenbaum, who's familiar with the findings. "I'm not sure how useful this is given we have several antiviral agents available. Why would we choose this over Paxlovid, remdesivir, or molnupiravir?"
According to Fichtenbaum, researchers began focusing on fluvoxamine after case reports about patients improving while on the medication. This led to further interest, he said, boosted by the drug's known ability to dampen the immune system.
Lead photo/Science News
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC medical students explore ChatGPT’s ability to support qualitative research
December 18, 2025
Newly published research in the journal Medical Science Educator highlights University of Cincinnati College of Medicine student-led work in medical education and examines how artificial intelligence can assist with qualitative research.
How to find joy while caregiving through the holidays
December 18, 2025
The University of Cincinnati's Robert Neel was featured in an AARP article discussing the biology of holiday stress for caregivers and ways to manage these intense emotions.
OKI Wanna Know: Braking for your highway traffic questions
December 18, 2025
In a WVXU segment, Professor Rebecca Borah explains how perception can shape what drivers think they see on Ohio roads. Borah says it can be attributed to the Mandela Effect.